Technology
Health
Biotechnology

Onconova Therapeutics

$2.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-4.87%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ONTX and other stocks, options, ETFs, and crypto commission-free!

About ONTX

Onconova Therapeutics, Inc. Common Stock, also called Onconova Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. Read More It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.

Employees
25
Headquarters
Newtown, Pennsylvania
Founded
1998
Market Cap
12.90M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
31.10K
High Today
$2.24
Low Today
$2.06
Open Price
$2.24
Volume
25.90K
52 Week High
$11.17
52 Week Low
$1.69

Collections

Technology
Health
Biotechnology
Therapy
Medical
Biopharmaceutical
Cancer Prevention
Pharmaceutical

ONTX News

ReutersAug 16

Edited Transcript of ONTX earnings conference call or presentation 14-Aug-19 1:00pm GMT

2

ONTX Earnings

-$1.29
-$0.88
-$0.48
-$0.07
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.82 per share
Actual
-$0.60 per share

More ONTX News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.